Medroxyprogesterone acetate

The recommended dose is 150 mg of medroxyprogesterone acetate injectable suspension every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle. 2.1 Prevention of Pregnancy Both the 1 mL vial and the 1 mL prefilled syringe of medroxyprogesterone acetate injectable suspension should be vigorously shaken just before use to ensure that the dose being administered represents a uniform suspension.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

The use of medroxyprogesterone acetate injectable suspension is contraindicated in the following conditions: Active thrombophlebitis, or current or history of thromboembolic disorders, or cerebral vascular disease. Known or suspected malignancy of breast. Known hypersensitivity to medroxyprogesterone acetate injectable suspension or any of its other ingredients. Significant liver disease. Undiagnosed vaginal bleeding. Active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Thromboembolic Disorders: Discontinue medroxyprogesterone acetate injectable suspension in patients who develop thrombosis. Cancer Risks: Monitor women with a strong family history of breast cancer carefully. Meningioma: Discontinue medroxyprogesterone acetate injectable suspension if meningioma is diagnosed. Monitor patients for signs and symptoms of meningioma. Ectopic Pregnancy: Consider ectopic pregnancy if a woman using medroxyprogesterone acetate injectable suspension becomes pregnant or complains of severe abdominal pain. Anaphylaxis and Anaphylactoid Reactions: Provide emergency medical treatment.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following important adverse reactions observed with the use of medroxyprogesterone acetate injectable suspension are discussed in greater detail in the Warnings and Precautions section: Loss of Bone Mineral Density Thromboembolic disease Breast Cancer Anaphylaxis and Anaphylactoid Reactions Bleeding Irregularities Weight Gain Most common adverse reactions (incidence >5%): menstrual irregularities (bleeding or spotting)…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

82 products from 62 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 82 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Stored upright at 20° to 25°C (68° to 77°F). Store at 20° to 25°C (68° to 77°F).

Storage information from the U.S. FDA-approved label.